Budesonide 4mg modified-release capsules
NHS hospitals in England used £24,826,566 of indicative cost of Budesonide 4mg modified-release capsules in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 47.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Budesonide 4mg modified-release capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Budesonide 4mg modified-release capsules most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Oxford University Hospitals Nhs Ft | £2,182,004 |
| Portsmouth Hospitals Nhs Trust | £1,429,846 |
| Manchester University Nhs Ft | £1,353,659 |
| Aintree University Hospital Nhs Ft | £1,005,374 |
| University Hpls North Midlands Nhs Trust | £948,965 |
| Imperial College Healthcare Nhs Trust | £875,392 |
| Salford Royal Nhs Foundation Trust | £809,855 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £748,998 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £744,317 |
| Epsom & St Helier Univ Hpls Nhs Trust | £649,288 |
The primary-care picture
Budesonide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Budesonide medicine page.